Trust Point Inc. trimmed its holdings in Chemed Co. (NYSE:CHE - Free Report) by 16.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,587 shares of the company's stock after selling 701 shares during the quarter. Trust Point Inc.'s holdings in Chemed were worth $1,900,000 at the end of the most recent reporting period.
Several other hedge funds also recently added to or reduced their stakes in the business. International Assets Investment Management LLC purchased a new stake in Chemed during the third quarter worth $437,150,000. FMR LLC raised its position in shares of Chemed by 23.8% in the third quarter. FMR LLC now owns 238,616 shares of the company's stock worth $143,401,000 after acquiring an additional 45,917 shares during the period. Thrivent Financial for Lutherans boosted its stake in shares of Chemed by 25.3% during the 3rd quarter. Thrivent Financial for Lutherans now owns 146,017 shares of the company's stock worth $87,752,000 after acquiring an additional 29,445 shares in the last quarter. Aureus Asset Management LLC grew its position in shares of Chemed by 3,147.2% during the 3rd quarter. Aureus Asset Management LLC now owns 29,939 shares of the company's stock valued at $17,993,000 after acquiring an additional 29,017 shares during the period. Finally, Allspring Global Investments Holdings LLC increased its stake in shares of Chemed by 143.5% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 42,267 shares of the company's stock valued at $25,401,000 after purchasing an additional 24,912 shares in the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Chemed
In related news, EVP Spencer S. Lee sold 732 shares of the stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total value of $421,353.84. Following the completion of the sale, the executive vice president now owns 18,287 shares of the company's stock, valued at approximately $10,526,362.94. This trade represents a 3.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Brian C. Judkins acquired 145 shares of the stock in a transaction on Monday, December 30th. The shares were bought at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the purchase, the vice president now directly owns 1,678 shares of the company's stock, valued at $871,721. The trade was a 9.46 % increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 3.32% of the company's stock.
Chemed Price Performance
Chemed stock traded down $3.31 during midday trading on Friday, reaching $550.53. The company had a trading volume of 69,735 shares, compared to its average volume of 93,249. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $654.62. The company has a market capitalization of $8.29 billion, a P/E ratio of 27.82, a P/E/G ratio of 2.19 and a beta of 0.48. The firm's fifty day simple moving average is $543.62 and its 200-day simple moving average is $564.38.
Analyst Upgrades and Downgrades
Several brokerages have commented on CHE. StockNews.com raised Chemed from a "hold" rating to a "buy" rating in a report on Saturday, November 30th. Royal Bank of Canada decreased their target price on Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a research report on Tuesday, November 5th.
Get Our Latest Research Report on Chemed
Chemed Profile
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Recommended Stories

Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.